July 31: Privi Speciality Chemicals Limited, an Indian specialty chemicals company and global manufacturer of aroma chemicals and fragrance ingredients, announced its financial results for the quarter ended June 30, 2026, delivering a strong start to FY27. The Company’s performance was driven by broad-based demand across domestic and export markets, disciplined execution and the resilience of its diversified business model despite an evolving global environment.
The Company continued to benefit from its integrated manufacturing capabilities, diversified customer base and long-standing relationships with leading global fragrance and flavour companies. Supported by continued investments in capacity augmentation, innovation and specialty products, Privi remains well positioned to capitalise on evolving global supply chain opportunities and deliver sustainable long-term growth.
Business Momentum Remained Resilient
Business momentum remained healthy during the quarter, supported by broad-based demand across both domestic and international markets. The Company continued to witness resilient demand from global fragrance and flavour customers while maintaining stable operations despite ongoing global headwinds. Its diversified geographic presence and integrated manufacturing capabilities enabled uninterrupted operations and reinforced its position as a reliable long-term supply partner.
The Company also continued to expand its specialty chemicals portfolio through investments in innovation, new product development and manufacturing capabilities, strengthening its ability to address evolving customer requirements and capture long-term growth opportunities.
Business Performance & Strategic Updates
- Total Income grew 20.01% year-on-year to Rs 681.42 crore.
- EBITDA increased 18.73% year-on-year to Rs 167.47 crore.
- Profit after Tax attributable to the Company increased 35.97% year-on-year to Rs 84.21 crore.
- The Company continues to maintain a strong balance sheet and healthy cash flows, supporting future growth initiatives.
Growth Strategy Remains on Track
- Expansion projects are progressing as planned and are expected to be ready for commercial operations in the second half of 2028.
- New product development continues to expand Privi’s addressable market and strengthen long-term customer relationships.
- The Company continues to invest in specialty molecule expansion, R&D, process innovation and capacity augmentation to support its long-term Vision 5K:1K roadmap.
- Privi remains focused on expanding its specialty product portfolio while improving operational efficiencies and strengthening its leadership position in global aroma chemicals.
Commenting on the performance, Mr. Mahesh Babani, Chairman & Managing Director, said,
“We have started FY27 on a strong note, delivering broad-based growth across our business despite an evolving global environment. Our performance reflects the resilience of our business model, disciplined execution and the strength of our diversified customer base across domestic and international markets. As we look ahead, our focus remains firmly on executing our long-term growth strategy through capacity augmentation, innovation, new product development and sustainable manufacturing. Our expansion projects are progressing well, and together with our strong R&D capabilities and integrated manufacturing platform, they position us to deepen customer partnerships and capture emerging opportunities in the global specialty chemicals industry. We remain confident in our Vision 5K:1K roadmap and our ability to create sustainable long-term value for all our stakeholders.”